The Clinical Trials Coordination Center (CTCC), a research unit of the University of Rochester’s Department of Neurology, operates to foster multi-institutional academic research through the development, management, and reporting of hypothesis-driven, controlled clinical trials.
Our mission is “to generate and convey new knowledge leading to treatments that improve health or quality of life.”
Under the direction of Ira Shoulson, M.D.; Karl Kieburtz, M.D., MPH; Bernard Ravina, M.D., M.S.C.E.; and Steve Schwid, M.D., the CTCC has been in operation since 1986, initially to support the NIH-sponsored DATATOP (Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism) trial. The CTCC has since grown to support a full array of services essential to clinical trial services for industry, foundation, and government sponsors. The CTCC works in close collaboration with the Department of Biostatistics at the University of Rochester to provide planning and analytical services.
The CTCC is utilized by several multi-center investigator-initiated consortia including the Parkinson Study Group (PSG), the Huntington Study Group (HSG), and the HIV Dementia Consortium. These study groups are comprised of more than 200 academic investigators from the United States, Canada, Europe, and Australia.
The CTCC is also the primary research training site for a NIH-funded training grant: Experimental Therapeutics in Neurological Disease, R.C. Griggs, PI (Clinical Neuroscience, #NS-07338).
Our Services
Clinical Trials Coordination Center Services
Contact Us
University of Rochester Medical Center
Department of Neurology
Clinical Trials Coordination Center
1351 Mt. Hope Avenue, Suite 223
Rochester, NY 14620
(585) 275-7311
Back to Movement Disorders Center page
Movement and Inherited Neurological Disorders
Research Information
Clinical Trials Coordination Center